Philip A May1,2, Christina D Chambers3,4, Wendy O Kalberg2, Jennifer Zellner3, Haruna Feldman3, David Buckley2, David Kopald3, Julie M Hasken1, Ronghui Xu3, Gordon Honerkamp-Smith3, Howard Taras3, Melanie A Manning5, Luther K Robinson6, Margaret P Adam7, Omar Abdul-Rahman8, Keith Vaux3, Tamison Jewett9, Amy J Elliott10, Julie A Kable11, Natacha Akshoomoff3, Daniel Falk12, Judith A Arroyo12, Dale Hereld12, Edward P Riley13, Michael E Charness14,15,16, Claire D Coles11, Kenneth R Warren12, Kenneth Lyons Jones3,4, H Eugene Hoyme17,18. 1. University of North Carolina at Chapel Hill, Gillings School of Global Public Health, Chapel Hill. 2. University of New Mexico, Center on Alcoholism, Substance Abuse and Addictions, Albuquerque. 3. University of California San Diego School of Medicine, La Jolla. 4. Rady Children's Hospital-San Diego, San Diego, California. 5. Stanford University School of Medicine, Stanford, California. 6. State University of New York Buffalo School of Medicine, Buffalo. 7. University of Washington School of Medicine, Seattle. 8. University of Nebraska Medical Center, Omaha. 9. Wake Forest University School of Medicine, Winston-Salem, North Carolina. 10. Avera McKennan Hospital and University Health Center, Sioux Falls, South Dakota. 11. Emory University School of Medicine, Atlanta, Georgia. 12. National Institute on Alcohol Abuse and Alcoholism, Bethesda, Maryland. 13. San Diego State University, Center for Behavioral Teratology, San Diego, California. 14. VA Boston Healthcare System, Boston, Massachusetts. 15. Harvard Medical School, Boston, Massachusetts. 16. Boston University School of Medicine, Boston, Massachusetts. 17. University of Arizona College of Medicine, Tucson. 18. Sanford Research, University of South Dakota Sanford School of Medicine, Vermillion.
Abstract
Importance: Fetal alcohol spectrum disorders are costly, life-long disabilities. Older data suggested the prevalence of the disorder in the United States was 10 per 1000 children; however, there are few current estimates based on larger, diverse US population samples. Objective: To estimate the prevalence of fetal alcohol spectrum disorders, including fetal alcohol syndrome, partial fetal alcohol syndrome, and alcohol-related neurodevelopmental disorder, in 4 regions of the United States. Design, Setting, and Participants: Active case ascertainment methods using a cross-sectional design were used to assess children for fetal alcohol spectrum disorders between 2010 and 2016. Children were systematically assessed in the 4 domains that contribute to the fetal alcohol spectrum disorder continuum: dysmorphic features, physical growth, neurobehavioral development, and prenatal alcohol exposure. The settings were 4 communities in the Rocky Mountain, Midwestern, Southeastern, and Pacific Southwestern regions of the United States. First-grade children and their parents or guardians were enrolled. Exposures: Alcohol consumption during pregnancy. Main Outcomes and Measures: Prevalence of fetal alcohol spectrum disorders in the 4 communities was the main outcome. Conservative estimates for the prevalence of the disorder and 95% CIs were calculated using the eligible first-grade population as the denominator. Weighted prevalences and 95% CIs were also estimated, accounting for the sampling schemes and using data restricted to children who received a full evaluation. Results: A total of 6639 children were selected for participation from a population of 13 146 first-graders (boys, 51.9%; mean age, 6.7 years [SD, 0.41] and white maternal race, 79.3%). A total of 222 cases of fetal alcohol spectrum disorders were identified. The conservative prevalence estimates for fetal alcohol spectrum disorders ranged from 11.3 (95% CI, 7.8-15.8) to 50.0 (95% CI, 39.9-61.7) per 1000 children. The weighted prevalence estimates for fetal alcohol spectrum disorders ranged from 31.1 (95% CI, 16.1-54.0) to 98.5 (95% CI, 57.5-139.5) per 1000 children. Conclusions and Relevance: Estimated prevalence of fetal alcohol spectrum disorders among first-graders in 4 US communities ranged from 1.1% to 5.0% using a conservative approach. These findings may represent more accurate US prevalence estimates than previous studies but may not be generalizable to all communities.
Importance: Fetal alcohol spectrum disorders are costly, life-long disabilities. Older data suggested the prevalence of the disorder in the United States was 10 per 1000 children; however, there are few current estimates based on larger, diverse US population samples. Objective: To estimate the prevalence of fetal alcohol spectrum disorders, including fetal alcohol syndrome, partial fetal alcohol syndrome, and alcohol-related neurodevelopmental disorder, in 4 regions of the United States. Design, Setting, and Participants: Active case ascertainment methods using a cross-sectional design were used to assess children for fetal alcohol spectrum disorders between 2010 and 2016. Children were systematically assessed in the 4 domains that contribute to the fetal alcohol spectrum disorder continuum: dysmorphic features, physical growth, neurobehavioral development, and prenatal alcohol exposure. The settings were 4 communities in the Rocky Mountain, Midwestern, Southeastern, and Pacific Southwestern regions of the United States. First-grade children and their parents or guardians were enrolled. Exposures: Alcohol consumption during pregnancy. Main Outcomes and Measures: Prevalence of fetal alcohol spectrum disorders in the 4 communities was the main outcome. Conservative estimates for the prevalence of the disorder and 95% CIs were calculated using the eligible first-grade population as the denominator. Weighted prevalences and 95% CIs were also estimated, accounting for the sampling schemes and using data restricted to children who received a full evaluation. Results: A total of 6639 children were selected for participation from a population of 13 146 first-graders (boys, 51.9%; mean age, 6.7 years [SD, 0.41] and white maternal race, 79.3%). A total of 222 cases of fetal alcohol spectrum disorders were identified. The conservative prevalence estimates for fetal alcohol spectrum disorders ranged from 11.3 (95% CI, 7.8-15.8) to 50.0 (95% CI, 39.9-61.7) per 1000 children. The weighted prevalence estimates for fetal alcohol spectrum disorders ranged from 31.1 (95% CI, 16.1-54.0) to 98.5 (95% CI, 57.5-139.5) per 1000 children. Conclusions and Relevance: Estimated prevalence of fetal alcohol spectrum disorders among first-graders in 4 US communities ranged from 1.1% to 5.0% using a conservative approach. These findings may represent more accurate US prevalence estimates than previous studies but may not be generalizable to all communities.
Authors: Philip A May; Amy Baete; Jaymi Russo; Amy J Elliott; Jason Blankenship; Wendy O Kalberg; David Buckley; Marita Brooks; Julie Hasken; Omar Abdul-Rahman; Margaret P Adam; Luther K Robinson; Melanie Manning; H Eugene Hoyme Journal: Pediatrics Date: 2014-11 Impact factor: 7.124
Authors: Sylvia Roozen; Gjalt-Jorn Y Peters; Gerjo Kok; David Townend; Jan Nijhuis; Leopold Curfs Journal: Alcohol Clin Exp Res Date: 2016-01 Impact factor: 3.455
Authors: H Eugene Hoyme; Wendy O Kalberg; Amy J Elliott; Jason Blankenship; David Buckley; Anna-Susan Marais; Melanie A Manning; Luther K Robinson; Margaret P Adam; Omar Abdul-Rahman; Tamison Jewett; Claire D Coles; Christina Chambers; Kenneth L Jones; Colleen M Adnams; Prachi E Shah; Edward P Riley; Michael E Charness; Kenneth R Warren; Philip A May Journal: Pediatrics Date: 2016-07-27 Impact factor: 7.124
Authors: Philip A May; Carol Keaster; Rosemary Bozeman; Joelene Goodover; Jason Blankenship; Wendy O Kalberg; David Buckley; Marita Brooks; Julie Hasken; J Phillip Gossage; Luther K Robinson; Melanie Manning; H Eugene Hoyme Journal: Drug Alcohol Depend Date: 2015-08-14 Impact factor: 4.492
Authors: Osman S Ipsiroglu; Katarina Wind; Yi-Hsuan Amy Hung; Mai Berger; Forson Chan; Wayne Yu; Sylvia Stockler; Joanne Weinberg Journal: Sleep Med Date: 2018-10-25 Impact factor: 3.492
Authors: Sandra W Jacobson; R Colin Carter; Christopher D Molteno; Mark E Stanton; Jane S Herbert; Nadine M Lindinger; Catherine E Lewis; Neil C Dodge; H Eugene Hoyme; Steven H Zeisel; Ernesta M Meintjes; Christopher P Duggan; Joseph L Jacobson Journal: Alcohol Clin Exp Res Date: 2018-06-15 Impact factor: 3.455
Authors: Ping Ye; Jyoti Angal; Deborah A Tobacco; Amy R Willman; Christa A Friedrich; Morgan E Nelson; Larry Burd; Amy J Elliott Journal: Am J Prev Med Date: 2020-02-12 Impact factor: 5.043
Authors: Krista D Sowell; Roberta R Holt; Janet Y Uriu-Adams; Christina D Chambers; Claire D Coles; Julie A Kable; Lyubov Yevtushok; Natalya Zymak-Zakutnya; Wladimir Wertelecki; Carl L Keen Journal: J Am Coll Nutr Date: 2020-04-02 Impact factor: 3.169